Lumry W - Search Results

1

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Riedl MA, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA, Bouillet L, Busse P, Manning M, Magerl M, Gompels M, Huissoon AP, Longhurst H, Lumry W, Ritchie B, Shapiro R, Soteres D, Banerji A, Cancian M, Johnston DT, Craig TJ, Launay D, Li HH, Liebhaber M, Nickel T, Offenberger J, Rae W, Schrijvers R, Triggiani M, Wedner HJ, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan WP, Maurer M. Riedl MA, et al. Among authors: lumry w. Allergy. 2018 Sep;73(9):1871-1880. doi: 10.1111/all.13466. Epub 2018 Jun 17. Allergy. 2018. PMID: 29688579 Free PMC article. Clinical Trial.

2

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.

van As A, Bronsky EA, Dockhorn RJ, Grossman J, Lumry W, Meltzer EO, Seltzer JM, Rogenes PR. van As A, et al. Among authors: lumry w. J Allergy Clin Immunol. 1993 Jun;91(6):1146-54. doi: 10.1016/0091-6749(93)90317-9. J Allergy Clin Immunol. 1993. PMID: 8509578 Clinical Trial.

3

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis.

Bernstein DI, Creticos PS, Busse WW, Cohen R, Graft DF, Howland WC, Lumry WR, Pedinoff AJ, Ratner PH, Lim J, Stokes A, McNally C. Bernstein DI, et al. Among authors: lumry wr. J Allergy Clin Immunol. 1996 Mar;97(3):749-55. doi: 10.1016/s0091-6749(96)80151-5. J Allergy Clin Immunol. 1996. PMID: 8613630 Clinical Trial.

4

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K. Wenzel SE, et al. Among authors: lumry w. Ann Allergy Asthma Immunol. 1998 Jun;80(6):463-70. doi: 10.1016/S1081-1206(10)63068-2. Ann Allergy Asthma Immunol. 1998. PMID: 9647268 Clinical Trial.

5

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.

Nayak AS, Banov C, Corren J, Feinstein BK, Floreani A, Friedman BF, Goldsobel A, Gottschlich GM, Hannaway PJ, Lampl KL, Lapidus RJ, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella AT, Schenkel EJ, Segal AT, Segall N, Silverman B, Shneyer L, Nolop KB, Harrison JE. Nayak AS, et al. Among authors: lumry w. Ann Allergy Asthma Immunol. 2000 Apr;84(4):417-24. doi: 10.1016/S1081-1206(10)62275-2. Ann Allergy Asthma Immunol. 2000. PMID: 10795650 Clinical Trial.

6

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.

Bensch G, Lapidus RJ, Levine BE, Lumry W, Yegen U, Kiselev P, Della Cioppa G. Bensch G, et al. Among authors: lumry w. Ann Allergy Asthma Immunol. 2001 Jan;86(1):19-27. doi: 10.1016/s1081-1206(10)62351-4. Ann Allergy Asthma Immunol. 2001. PMID: 11206232 Clinical Trial.

7

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.

Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B. Karpel JP, et al. Among authors: lumry w. Respir Med. 2007 Mar;101(3):628-37. doi: 10.1016/j.rmed.2006.06.005. Epub 2006 Jul 26. Respir Med. 2007. PMID: 16875813 Free article. Clinical Trial.

8

Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.

Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T. Schneider L, et al. Among authors: lumry w. J Allergy Clin Immunol. 2007 Aug;120(2):416-22. doi: 10.1016/j.jaci.2007.04.028. Epub 2007 Jun 7. J Allergy Clin Immunol. 2007. PMID: 17559913 Clinical Trial.

9

Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.

Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Shah S, et al. Among authors: lumry w. Allergy Asthma Proc. 2009 Nov-Dec;30(6):628-33. doi: 10.2500/aap.2009.30.3296. Epub 2009 Nov 19. Allergy Asthma Proc. 2009. PMID: 19930788 Clinical Trial.

10

Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.

Nathan RA, Nolte H, Pearlman DS; P04334 Study Investigators. Nathan RA, et al. Allergy Asthma Proc. 2010 Jul-Aug;31(4):269-79. doi: 10.2500/aap.2010.31.3364. Epub 2010 Jul 30. Allergy Asthma Proc. 2010. PMID: 20678306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters